shadow_tr

Prostate Studies
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -



AZ Profound
A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have Homologous Recombination Repair Gene Mutations (PROfound)
More Information


BAY 16996
A Phase 4 Long-Term Follow-Up Study to Define the Safety Profile of Radium-223 Dichloride
More Information


BAY 17777
A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients With Metastatic Hormone-Sensitive Prostate Cancer
More Information


BAY 18919
Management, Treatment Patterns and Outcomes of Metastatic Castrate Resistant Prostate Cancer Patients Treated with Radium-223
More Information


NRG GU002
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
More Information


PRC2001
A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration Resistant Prostate Cancer and DNA Repair Anomalies
More Information


J1522
A Phase 2 Study of Sipuleucel-T With or Without Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-Metastatic Castrate-Resistant Prostate Cancer
More Information


MK3475-199
Phase II Trial of Pembrolizumab (MK-3475) in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Chemotherapy (KEYNOTE-199)
More Information



INO-VT-464-CL-003
A Single-Arm, Phase II Study to Evaluate the Safety and Efficacy of VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone
More Information


INFLAMMATION
Comprehensive Genetic Characterization of Intraprostatic Chronic Inflammation and Prostate Cancer in
African American Men


TASTE
Taste in Prostate Cancer

TRANSFORMER
A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic
Men with Castration Resistant Metastatic Prostate Cancer: The TRANSFORMER Trial
More Information


GU 115
A Double-Blinded, Placebo-Controlled, Randomized Phase II Trial of Enzalutamide With or Without the PI3 Kinase/m TOR Inhibitor LY3023414 in Men with Metastatic Castration Resistant Prostate Cancer

More Information


EC1169-01
A Phase I Study of a Prostate-Specific Membrane Antigen Targeting-Tubulysin Conjugate EC1169 in Patients With Recurrent Metastatic, Castration-Resistant Prostate Cancer (mCRPC)
More Information


Sotio SP005
A Randomized, Double Blind, Multicenter, Parallel-Group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
More Information


P12-1

A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer (PREDICT)
More Information



RTOG 0924
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy In Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
More Information


TUHC 07/25/13 - Genetics of Prostate Cancer


SWOG S1216

A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
More Information



1430 Tulane Ave, New Orleans, LA 70112 medsch@tulane.edu